Oncology PracticeCORD Offers Consensus Framework for Ethical CollaborationFebruary 17, 2017Rare Diseases
Oncology PracticeNORD Seeks Input Regarding Patient Protections and ACAFebruary 17, 2017Rare Diseases
Oncology PracticeNivolumab safe, effective for salvage in advanced gastric cancerJanuary 21, 2017GastroenterologyImmunotherapyRare DiseasesGastrointestinal Cancer
Hematology NewsVIDEO: Despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host diseaseJanuary 18, 2017Cellular TherapyPatient & Survivor CareRare Diseases
Hematology NewsPERSIST-2 might allay some concerns about pacritinib in myelofibrosisJanuary 9, 2017Myelodysplastic SyndromeRare Diseases
Oncology PracticeAWaRDS Study Examines Services for Adults With Rare DisordersJanuary 9, 2017Rare Diseases
Oncology PracticeJoin Others Around the World in Observing Rare Disease DayJanuary 9, 2017Rare Diseases
Oncology PracticeNORD Report Shows Majority of States Fall Short on Reducing Burden of Living With a Rare DiseaseJanuary 9, 2017Rare Diseases
Oncology PracticeNominate a Patient or Colleague for a NORD Rare Impact AwardJanuary 6, 2017Rare Diseases
Hematology NewsBrentuximab vedotin beat methotrexate, bexarotene in cutaneous T-cell lymphomaDecember 6, 2016T Cell LymphomasRare DiseasesLymphoma & Plasma Cell Disorders
Oncology PracticeJanuary 13 Is Deadline for NORD Rare Impact Award NominationsDecember 2, 2016Rare Diseases
Oncology PracticeMajor Three-Year Study of Undiagnosed Diseases Announced December 1, 2016Rare Diseases
